Agilent Technologies Introduces Dissolution Apparatus for Pharmaceutical Quality Control
Platform Sets New Global Standard for Dissolution
SANTA CLARA, Calif., Agilent Technologies Inc. (NYSE: A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and automated applications. The new device includes an improved design that minimizes variability and improves results. Dissolution is a technique used in the pharmaceutical industry to determine the rate at which pure active pharmaceutical ingredients dissolve.
“Agilent is committed to maintaining Varian’s tradition of excellence in dissolution and establishing a new standard for pharmaceutical companies and other firms operating in a global marketplace,” said Frank Riba, Agilent business manager, Dissolution Division. “The new 708-DS Dissolution Apparatus yields the sample-to-sample consistency that is critical for scientists assessing batch-to-batch performance, bioequivalency and other characteristics of their compounds.”
The 708-DS Dissolution Apparatus is available as a basic manual model and in a variety of automated configurations for high-throughput online sampling and online UV analysis. The apparatus allows for several advanced usage options, including temperature monitoring, automated dosage delivery and in-situ fiber optic analysis. Customized add-ons allow a variety of dosage types to be analyzed on the same apparatus.
The design of the 708-DS Dissolution Apparatus conforms to internationally harmonized pharmacopeia specifications for basket, paddle, rotating cylinder, intrinsic and paddle-over-disk configurations. The apparatus can test tablets, capsules and a wide variety of other dosage forms.
In addition to the dissolution apparatus hardware and software, Agilent offers users peace of mind by providing high-quality service for the DS-708 Dissolution Apparatus around the globe, including:
* qualification documentation for the entire system;
* trained chemists to perform the installation and qualification;
* standard operating procedure templates;
* technical support for drug release methods, equipment and regulatory questions; and
* sponsorship for the vendor-neutral online Dissolution Discussion Group forum.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.